BioCardia, Inc. — Director's Dealing 2020

Nov 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-11-02

Reporting Person: Duckers Eric (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-02	Common Stock	S	8435	$2.01	Disposed	12088	Direct

Footnotes

F1: This transaction was executed in multiple trades ranging from $2.00 to $2.02 per share. The price reported above reflects the weighted average per share sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares sold at each separate price.